NSE List Price : ₹172.10

subscription

Category	Times
QIBs	63.31x
HNIs	136.1x
Retail	54.21x
Total : 74.43x

IPO Market Lot(s) Distribution

Application	Lot Size	Shares	Amount
Retail Minimum	2	2,000	₹270,000
Retail Maximum	2	2,000	₹270,000
S-HNI Minimum	3	3,000	₹405,000
S-HNI Maximum	7	7,000	₹945,000
B-HNI Minimum	8	8,000	₹1,080,000

About the Company

Incorporated on 3 September 2019, KRM Ayurveda Ltd operates a chain of Ayurvedic hospitals and clinics across India, while also extending its reach internationally through telemedicine services and the sale of Ayurvedic products.

The company currently manages 6 hospitals and 5 clinics across various locations, delivering comprehensive and integrated Ayurvedic healthcare solutions.

KRM Ayurveda is engaged in the manufacturing of Ayurvedic formulations, herbal and botanical medicines, nutritional supplements, and wellness and skincare products.

Its service portfolio includes in-patient hospital treatments, out-patient clinic consultations, teleconsultation offerings, and the distribution of KRM-branded Ayurvedic products.

As of August 31, 2025, the organisation has a workforce of 429 employees spanning medical, operational, and administrative functions.

The proceeds from the IPO are proposed to be utilised for setting up telemedicine infrastructure (?13.67 crore), strengthening CRM and IT systems (?1.42 crore), recruitment and human resource development (?5.44 crore), repayment of borrowings (?12.50 crore), funding working capital requirements (?18.00 crore), and for general corporate purposes.

Company Financial Report

_{Amount ₹ in Crores}

Period Ended	Revenue	Expense	PAT	Assets
2023	₹89.38	₹79.29	₹7.60	₹39.48
2024	₹67.57	₹62.85	₹3.41	₹43.91
2025	₹76.95	₹60.61	₹12.10	₹66.79
Sep 2025	₹48.65	₹37.65	₹8.14	₹78.12

Company Promoter

Mr. Puneet Dhawan

Mrs. Tanya Dhawan

Know before investing

• • Strengths

  Recognised brand with loyal clientele – Repeat patronage supports stable revenues and long-term brand strength.

  Experienced Ayurvedic practitioners – Trained doctors and certified therapists maintain high standards of treatment quality.

• • Risks

  Regional revenue concentration – A significant portion of revenue comes from the top two states, increasing exposure to location-specific risks.

  Reliance on leased premises – Use of rented hospitals and office spaces exposes the company to potential disruption if relocation becomes necessary.

Objects of the Issue & Utilisation of proceeds

Capital Expenditure for Construction and Development of Telemedicine Operational Facilities.
Purchase of CRM Software and Hardware Infrastructure.
Human Resources.
Repayment/Prepayment of loan.
Working Capital Requirement.
General Corporate Purpose.

Company  Address

KRM Ayurveda Ltd.
A-16
G T Karnal road
North West Delhi, New Delhi, 110033
Phone: +91-9289101700
Email: compliance@krmayurveda.com
Website: https://www.krmayurvedaindia.com/

IPO Registrar

Skyline Financial Services Pvt. Ltd.
Phone: 02228511022
Email: ipo@skylinerta.com
Website: https://www.skylinerta.com/ipo.php

IPO Review

Avoid